临床试验/NCT01608659

NCT01608659已完成不适用

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Allergan0 个研究点目标入组 110 人开始时间: 2011年4月1日最近更新: 2019年4月17日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Allergan
入组人数: 110
主要终点: Average Total Dose Per Treatment Period

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•Previously treated for glabellar lines (hyperfunctional facial lines) with botulinum toxin Type A preparation
•Received 2 treatment cycles wtih botulinum toxin Type A (BOTOX®) prior to at least 1 treatment with botulinum toxin Type A (Xeomin®)

排除标准

未提供

研究组 & 干预措施

botulinum toxin Type A

Previous treatment with botulinum toxin Type A for treatment of facial lines

干预措施: botulinum toxin Type A (Drug)

结局指标

主要结局

Average Total Dose Per Treatment Period

时间窗: 24 Months

Average total dose per treatment period was defined as total treatment dose plus total touch-up dose plus total follow-up dose.

次要结局

Percent of Subjects Reporting Satisfaction With Treatment Effects(24 Months)
Inter-Injection Interval Duration of Each Treatment Period(24 Months)

研究者

发起方

Allergan

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive BladderUrinary Bladder, OveractiveUrinary Bladder, Neurogenic

NCT02673047Allergan474

已完成

不适用

A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic MigrainesChronic Migraine, Headaches

NCT01749410Allergan33

撤回

不适用

Botox for Gummy SmileGingival Exposure

NCT03284047Northwestern University

已完成

3 期

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple SclerosisOveractive Bladder

NCT00876447Allergan397

已完成

2 期

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic NeuralgiaPostherpetic Neuralgia

NCT00168441Allergan117